Historical shareholding details of UBS Asset Mgmt Americas Inc holdings in Revance Therapeutics Inc (RVNC)

Monthly changes of UBS Asset Mgmt Americas Inc shareholding in Revance Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Sep 30, 2024 Ubs Asset Mgmt Americas Inc 265,210 0.25%
Jun 30, 2024 Ubs Asset Mgmt Americas Inc 237,790 0.23%
Mar 31, 2024 Ubs Asset Mgmt Americas Inc 119,361 0.11%
Dec 31, 2023 Ubs Asset Mgmt Americas Inc 119,361 0.11%
Sep 30, 2023 Ubs Asset Mgmt Americas Inc 110,675 0.13%
Jun 30, 2023 Ubs Asset Mgmt Americas Inc 90,914 0.10%
Mar 31, 2023 Ubs Asset Mgmt Americas Inc 90,914 0.10%
Dec 31, 2022 Ubs Asset Mgmt Americas Inc 78,986 0.09%

View all ownership details of Revance Therapeutics Inc